405 related articles for article (PubMed ID: 27025860)
1. Efficacy of laser therapy in the management of bisphosphonate-related osteonecrosis of the jaw (BRONJ): a systematic review.
Weber JB; Camilotti RS; Ponte ME
Lasers Med Sci; 2016 Aug; 31(6):1261-72. PubMed ID: 27025860
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) therapy. A critical review.
Vescovi P; Nammour S
Minerva Stomatol; 2010 Apr; 59(4):181-203, 204-13. PubMed ID: 20360666
[TBL] [Abstract][Full Text] [Related]
3. Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review.
Fliefel R; Tröltzsch M; Kühnisch J; Ehrenfeld M; Otto S
Int J Oral Maxillofac Surg; 2015 May; 44(5):568-85. PubMed ID: 25726090
[TBL] [Abstract][Full Text] [Related]
4. Management of bisphosphonate-related osteonecrosis of the jaw: a literature review.
Spanou A; Lyritis GP; Chronopoulos E; Tournis S
Oral Dis; 2015 Nov; 21(8):927-36. PubMed ID: 25732104
[TBL] [Abstract][Full Text] [Related]
5. Doxycycline fluorescence-guided Er:YAG laser ablation combined with Nd:YAG/diode laser biostimulation for treating bisphosphonate-related osteonecrosis of the jaw.
Porcaro G; Amosso E; Scarpella R; Carini F
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Jan; 119(1):e6-e12. PubMed ID: 25174873
[TBL] [Abstract][Full Text] [Related]
6. Early surgical laser-assisted management of bisphosphonate-related osteonecrosis of the jaws (BRONJ): a retrospective analysis of 101 treated sites with long-term follow-up.
Vescovi P; Manfredi M; Merigo E; Guidotti R; Meleti M; Pedrazzi G; Fornaini C; Bonanini M; Ferri T; Nammour S
Photomed Laser Surg; 2012 Jan; 30(1):5-13. PubMed ID: 22054203
[TBL] [Abstract][Full Text] [Related]
7. Current management concepts for bisphosphonate-related osteonecrosis of the jaw: a review.
Kilic E; Doganay O
Gen Dent; 2018; 66(6):e1-e5. PubMed ID: 30444713
[TBL] [Abstract][Full Text] [Related]
8. Surgical management of bisphosphonate-related osteonecrosis of the jaws: literature review.
Silva LF; Curra C; Munerato MS; Deantoni CC; Matsumoto MA; Cardoso CL; Curi MM
Oral Maxillofac Surg; 2016 Mar; 20(1):9-17. PubMed ID: 26659615
[TBL] [Abstract][Full Text] [Related]
9. Laser surgery in management of medication-related osteonecrosis of the jaws: a meta-analysis.
Momesso GAC; Lemos CAA; Santiago-Júnior JF; Faverani LP; Pellizzer EP
Oral Maxillofac Surg; 2020 Jun; 24(2):133-144. PubMed ID: 32056052
[TBL] [Abstract][Full Text] [Related]
10. Autologous platelet concentrates for bisphosphonate-related osteonecrosis of the jaw treatment and prevention. A systematic review of the literature.
Del Fabbro M; Gallesio G; Mozzati M
Eur J Cancer; 2015 Jan; 51(1):62-74. PubMed ID: 25466505
[TBL] [Abstract][Full Text] [Related]
11. Bisphosphonate-related osteonecrosis of the jaw: a review of the potential efficacy of low-level laser therapy.
Latifyan S; Genot MT; Klastersky J
Support Care Cancer; 2016 Sep; 24(9):3687-93. PubMed ID: 27029476
[TBL] [Abstract][Full Text] [Related]
12. [Bisphosphonate-related osteonecrosis of the jaw].
Atanes-Bonome P; Atanes-Bonome A; Ríos-Lage P; Atanes-Sandoval AD
Semergen; 2014 Apr; 40(3):143-8. PubMed ID: 24001573
[TBL] [Abstract][Full Text] [Related]
13. A systematic review of therapeutical approaches in bisphosphonates-related osteonecrosis of the jaw (BRONJ).
Rupel K; Ottaviani G; Gobbo M; Contardo L; Tirelli G; Vescovi P; Di Lenarda R; Biasotto M
Oral Oncol; 2014 Nov; 50(11):1049-57. PubMed ID: 25240948
[TBL] [Abstract][Full Text] [Related]
14. Bisphosphonate-related osteonecrosis of the jaws: Report of a case using conservative protocol.
Heggendorn FL; Leite TC; Cunha KS; Junior AS; Gonçalves LS; da Costa KB; Dias EP
Spec Care Dentist; 2016 Jan; 36(1):43-7. PubMed ID: 26782365
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphonate-related osteonecrosis: laser-assisted surgical treatment or conventional surgery?
Atalay B; Yalcin S; Emes Y; Aktas I; Aybar B; Issever H; Mandel NM; Cetin O; Oncu B
Lasers Med Sci; 2011 Nov; 26(6):815-23. PubMed ID: 21809068
[TBL] [Abstract][Full Text] [Related]
16. Medication-Related Osteonecrosis of the Jaw: An Autofluorescence-Guided Surgical Approach Performed with Er:YAG Laser.
Vescovi P; Giovannacci I; Otto S; Manfredi M; Merigo E; Fornaini C; Nammour S; Meleti M
Photomed Laser Surg; 2015 Aug; 33(8):437-42. PubMed ID: 26226174
[TBL] [Abstract][Full Text] [Related]
17. Is the conservative non-surgical management of medication-related osteonecrosis of the jaw an appropriate treatment option for early stages? A long-term single-center cohort study.
Ristow O; Rückschloß T; Müller M; Berger M; Kargus S; Pautke C; Engel M; Hoffmann J; Freudlsperger C
J Craniomaxillofac Surg; 2019 Mar; 47(3):491-499. PubMed ID: 30642734
[TBL] [Abstract][Full Text] [Related]
18. Bisphosphonate-associated osteonecrosis of the jaws: surgical treatment with ErCrYSGG-laser. Case report.
Rugani P; Acham S; Truschnegg A; Obermayer-Pietsch B; Jakse N
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Dec; 110(6):e1-6. PubMed ID: 21112522
[TBL] [Abstract][Full Text] [Related]
19. Medication-related osteonecrosis of the jaw: Is autologous platelet concentrate application effective for prevention and treatment? A systematic review.
Lopez-Jornet P; Sanchez Perez A; Amaral Mendes R; Tobias A
J Craniomaxillofac Surg; 2016 Aug; 44(8):1067-72. PubMed ID: 27318752
[TBL] [Abstract][Full Text] [Related]
20. [Bisphosphonate and denosumab-related osteonecrosis of the jaw: Epidemiology, diagnosis and management].
Dupic G; Collangettes D; Dillies AF; Calvet L; Tournilhac O; Bay JO; Mahammedi H
Bull Cancer; 2015 Dec; 102(12):1010-9. PubMed ID: 26607453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
